ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection
SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio")…
Jungbunzlauer Tricalcium Citrate Excipient Demonstrates Outstanding Results in Direct Compression Study
- New research confirms Jungbunzlauer's TCC TB supports efficient, high-quality tablet manufacturing…
Jupiter Endovascular Announces Positive Results From SPIRARE I First-in-human Study Presented at TCT 2025
Vertex Pulmonary Embolectomy System with Transforming Fixation (TFX) Technology Demonstrates Excellent Safety,…
The Shaw Prize Award Presentation Ceremony 2025: Continuing 22 Years of Legacy in Science and Innovation
HONG KONG, Oct. 21, 2025 /PRNewswire/ -- The Shaw Prize presented its…
Sinocare Showcases Its Comprehensive Diabetes Management Solutions at EASD
VIENNA, Oct. 15, 2025 /PRNewswire/ -- The 61st Annual Meeting of the…
HKUST Deepens Sweden Ties Positioning Hong Kong as a Strategic Nexus for Sino-Swedish Innovation
HONG KONG, Sept. 14, 2025 /PRNewswire/ -- A high-level delegation from The…
The 2025 International Congress of Basic Science Opens in Beijing
BEIJING, July 22, 2025 /PRNewswire/ -- The 2025 International Congress of Basic…
Bay Area Lyme Foundation Announces National Winner of the 2025 Emerging Leader Award to Develop a Much-Needed Rapid, Low-Cost, Easy-to-Use Lyme Disease Test
PORTOLA VALLEY, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme…
New data show Roches Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancer
The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than…